Advertisement

Growth factors and receptors in ovarian cancer

  • R. Leake
  • A. Barber
  • O. Owens
  • S. Langdon
  • B. Miller

Abstract

Repair of the normal ovarian epithelium, subsequent to the damage inflicted by ovulation, is thought to be carried out by epidermal growth factor (EGF) acting through its receptor (EGFR). In many tumour cells, it has been shown [1] that the role of EGF is taken by transforming growth factor-α, (TGF-α,). In breast cancer, there is firm evidence that overexpression of EGFR is associated with poor prognosis [2], implying a role for this receptor in promoting tumour progression. Thus, TGF-α, may, through the EGF receptor, be a driving force in the growth of some ovarian cancers. If so, blocking either growth factor or receptor function may have therapeutic implications. This study set out to establish the levels and frequency at which TGF-α, and EGFR can be detected in human ovarian epithelial cancers. Concurrently, in an effort to create model systems for testing potential drugs, ovarian cancer cell lines and xenografts were established and characterized in terms of sensitivity to EGF/TGF-α, and the corresponding levels and frequency of detection of endogenous EGFR and TGF-α, determined.

Keywords

Ovarian Cancer Epidermal Growth Factor Receptor Tyrosine Kinase Activity Human Ovarian Cancer Scatchard Analysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sporn, M.B. and Roberts, A.B. (1986) Peptide growth factors and inflammation, tissue repair and cancer, Clin. Invest., 78,329–32.CrossRefGoogle Scholar
  2. 2.
    Nicholson S., Sainsbury, J.R.C., Halcrow, P. et al., (1989) Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet, i, 182–4.CrossRefGoogle Scholar
  3. 3.
    Owens, O.J., Stewart C. and Leake, R.E. (1991) Growth factors in ovarian cancer. Br. J. Cancer, 64,1177–81.PubMedCrossRefGoogle Scholar
  4. 4.
    Leake, R.E., Cowan, S. and Eason, R. (1987) Computer program for Scatchard analysis of proteinrligand interaction. In Steroid Hormones: A Practical Approach, (eds B. Green and R.E. Leake), Oxford University Press, Oxford, pp. 93–7.Google Scholar
  5. 5.
    Owens, O.J., Stewart, C., Brown, I. and Leake, R.E. (1991) Epidermal growth factor receptors (EGFR) in human ovarian cancer. Br. J. Cancer, 64,907–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Langdon, S.P., Lawrie, S.S., Hay, F.G. et al., (1988) Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res., 48,6166–72.PubMedGoogle Scholar
  7. 7.
    Vindelov, L.L., Christenen, I.J. and Nissen, N.I. (1983) A detergent/trypsin method for the preparation of nuclei for flow cytometric analysis. Cytometry, 3,317–39.PubMedCrossRefGoogle Scholar
  8. 8.
    Crew, A.J., Langdon, S.P., Miller E.P. and Miller, W.R. (1992) Mitogenic effects of epidermal growth factor and transforming growth factor-α, on EGF-receptor positive human ovarian carcinoma cell lines. Eur. J. Cancer, 28, 337–41.PubMedCrossRefGoogle Scholar
  9. 9.
    Harding, M., Mcintosh, J., Paul, J. et al., (1990) Oestrogen and progesterone receptors in ovarian tumours. Cancer, 65,486–92.PubMedCrossRefGoogle Scholar
  10. 10.
    Berchuck, A., Rodriguez, G.C., Kael, A. et al., (1991) Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. Am. J. Obstet. Gynecol., 164, 669–74.PubMedGoogle Scholar
  11. 11.
    Owens, O.J., Stewart, C., Leake, R.E. and McNicol, A.M. (1992) A comparison of biochemical and immunohistochemical assessment of EGFR expression in ovarian cancer. Anticancer Res., 12,1455–8.PubMedGoogle Scholar
  12. 12.
    Bauknecht, T., Runge, M., Schwall, M. and Pfleiderer, A. (1988) Occurrence of epidermal growth factor receptors in human adnexal tumours and their prognostic value in advanced ovarian cancer.Gynecol. Oncol., 29, 147–57.PubMedCrossRefGoogle Scholar

Copyright information

© Chapman & Hall 1995

Authors and Affiliations

  • R. Leake
  • A. Barber
  • O. Owens
  • S. Langdon
  • B. Miller

There are no affiliations available

Personalised recommendations